Citation Impact
Citing Papers
Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial
2019
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Factors affecting the implementation of childhood vaccination communication strategies in Nigeria: a qualitative study
2017 Standout
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
2013 StandoutNobel
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility
2010
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Burden of liver diseases in the world
2018 Standout
Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
2014
Cost–Effectiveness of Hepatitis C Virus Antiviral Treatment for Injection Drug User Populations
2011
Hepatitis C: The next 25 years
2014 StandoutNobel
The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM)
2015
Predicting risk of cancer during HIV infection
2013
COVID-19: A promising cure for the global panic
2020 Standout
Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review
2014
Lymphogranuloma venereum presenting as genital ulceration and inguinal syndrome in men who have sex with men in London, UK
2008
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
2007 Standout
Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications
2014 Standout
HIV/HCV Co-infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic Technologies
2011
Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs
2015
Lymphogranuloma venereum among men who have sex with men in the Netherlands: regional differences in testing rates lead to underestimation of the incidence, 2006-2012
2013
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
2013 Standout
Can hepatitis C virus infection be eradicated in people who inject drugs?
2014
Hepatitis C Virus Infection in Pregnancy
2020
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection
2010
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
2010
HCV epidemiology in high-risk groups and the risk of reinfection
2016
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
2013
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
2017 Standout
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013
2016
Manifestations and management of lymphogranuloma venereum
2008
Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries
2010
Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
2012 Standout
Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis
2012 Standout
International trends in anal cancer incidence rates
2016
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Injection Drug Use and Hepatitis C Virus Infection in Young Adult Injectors: Using Evidence to Inform Comprehensive Prevention
2013
Elimination of Hepatitis C Virus Infection Among People Who Inject Drugs Through Treatment as Prevention: Feasibility and Future Requirements
2013
Current Trends of Immunization in Nigeria: Prospect and Challenges
2014
Screening for HIV Infection in Pregnant Women
2019
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
2020 Standout
Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs
2019 StandoutNobel
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Large ongoing measles outbreak in a religious community in the Netherlands since May 2013
2013
Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review
2018
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States
2017 Standout
Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?
2015
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
2017
Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents
2010
Dengue type 3 virus infections in European travellers returning from the Comoros and Zanzibar, February-April 2010
2010
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
2017
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
Guidelines for the management of hemophilia
2012 Standout
Effects ofMentha suaveolensEssential Oil onChlamydia trachomatis
2015 Standout
Works of Colette Smit being referenced
Risk of Hepatitis-Related Mortality Increased Among Hepatitis C Virus/HIV-Coinfected Drug Users Compared With Drug Users Infected Only With Hepatitis C Virus
2008
Low mother-to-child-transmission rate of Hepatitis C virus in cART treated HIV-1 infected mothers
2015
Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy
2011
Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study
2006
Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age
2018
Hospitalizations during a measles epidemic in the Netherlands, 1999 to 2000
2002
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users
2007
Lymphogranuloma Venereum Proctitis in Men Who Have Sex With Men Is Associated With Anal Enema Use and High-Risk Behavior
2008
Brief Report
2015
Favourable SVR12 rates with boceprevir or telaprevir triple therapy in HIV/HCV coinfected patients.
2015